Berlin, Germany

Holger Stark

This inventor holds 1 USPTO granted patent and 1 published patent application. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Holger Stark. Retrieved from https://idiyas.com/inventor/holger-stark-2pucxiwm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Holger Stark: Innovator in Therapeutic Applications

Introduction

Holger Stark is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on imidazole compounds. His research focuses on the therapeutic applications of these compounds, which have potential benefits in various medical treatments.

Latest Patents

Holger Stark holds a patent for "Imidazole compounds and their therapeutic applications." This patent encompasses a compound selected from a specific group consisting of a compound of the formula. His work in this area highlights the importance of imidazole compounds in developing new therapeutic strategies.

Career Highlights

Throughout his career, Holger Stark has demonstrated a commitment to advancing scientific knowledge and improving healthcare outcomes. His innovative approach to research has led to the development of valuable compounds that can be utilized in therapeutic settings.

Collaborations

Holger Stark has collaborated with esteemed colleagues, including Monique Garbarg and Charon R Ganellin. These partnerships have enriched his research and contributed to the successful development of his patented compounds.

Conclusion

Holger Stark's contributions to the field of medicinal chemistry through his patent on imidazole compounds exemplify the impact of innovation in healthcare. His work continues to inspire future research and development in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…